Arthur Cox advises Alkermes plc on the deal. Alkermes plc completed the separation of its oncology business into Mural Oncology plc, a new, independent, publicly traded company...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Seagate Technology PLC on the deal. Seagate Technology Holdings PLC sold $1.5 billion exchangeable senior unsecured notes due 2028. The capped call transactions...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Avadel Pharmaceuticals plc (Nasdaq: AVDL). Avadel Pharmaceuticals is a biopharmaceutical company focused on transforming medicines to transform lives. The company’s approach includes applying...
You must be a Standard 1 Year member to access this content.
Arthur Cox advised Avadel Pharmaceuticals plc (Nasdaq: AVDL). Jefferies LLC is acting as the sole book-running manager for the offering. LifeSci Capital LLC is acting as...
You must be a Standard 1 Year member to access this content.
Arthur Cox and Greenberg Traurig advised Concord Acquisition Corp. on the deal. Concord Acquisition Corp., a publicly traded special purpose acquisition company, will combine with Circle...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Matheson advised Circle on the deal. Arthur Cox and Greenberg Traurig advised Concord Acquisition Corp. Circle announced its definitive business combination agreement with Concord...
You must be a Standard 1 Year member to access this content.
